Niche and Leveraged ETFs Flood the Market: AI Memory and Macro Hedges Lead the Pack
Complete. Here is the key summaryWall Street is accelerating the launch of hyper-targeted thematic and leveraged ETFs in 2026. Asset managers are aggressively building tactical tools around AI infrastructure and macro hedges.
Wall Street's ETF market is undergoing a highly customized issuing frenzy. I'm told that as investor demand for hyper-granular exposure surges, asset managers have densely rolled out tactical tools targeting specific niches of the AI supply chain and multi-directional strategies throughout the first half of 2026. This is the most significant overhaul of thematic product lines I've seen since last year, and more vertical funds are expected to debut later this year.
Kurv Memory Select ETF (KMEM.US)
Launched in early July 2026, this ETF is taking a remarkably surgical approach. According to people familiar with the matter, KMEM bypasses broad-based semiconductors entirely to focus exclusively on SK Hynix, Samsung, and Micron, capitalizing on long-term supply bottlenecks in HBM, DRAM, and NAND. Internal projections at Kurv suggest these memory constraints will persist for at least the next three to four years, and they are reportedly favoring SK Hynix for its relatively low valuation.
Tema Photonics & Optical ETF (LAZR.US)
If you're still solely focused on traditional GPUs, you might be missing the next layer of the data transfer battle. Tema, in partnership with SemiAnalysis, rolled out LAZR at the end of June 2026. I've learned this is one of the first institutionally managed ETFs dedicated to photonics and optical infrastructure. With the market opportunity for advanced AI data transfer expected to grow ninefold by 2028, LAZR has been drawing significant attention from forward-looking capital recently.
Defiance Daily Target 2X Long DRAM ETF (DRAL.US)
For active traders who find unleveraged memory chips too dull, Defiance dropped DRAL on June 24, 2026. Utilizing options and swaps, this fund aims to deliver 2x the daily performance of the Roundhill Memory ETF. I'm told this product is absolutely not meant for buy-and-hold portfolios, but it's rapidly becoming a go-to instrument for hedge funds navigating intraday volatility in the semiconductor cycle.
State Street Bridgewater All Weather ETF (ALLW.US)
Amidst macroeconomic uncertainty, the State Street and Bridgewater collaboration ALLW is vacuuming up a staggering amount of capital. Launched in March 2025, the fund recently swept multiple awards in 2026, including "Best New Multi-Asset ETF." According to the latest data, its assets under management had quickly climbed to well over USD 1B by the end of April 2026, proving its massive fundraising power in a choppy market environment.
Direxion Shares ETF Trust Daily CSI 300 China A Sh Bull 2X Shs (CHAU.US)
Among tools targeting Asian markets, CHAU offers 2x daily leveraged exposure to the CSI 300 Index. Notably, the fund paid a dividend of USD 0.45 per share over the past year, translating to a 1.85% yield, with its latest ex-dividend date landing on June 23, 2026. Structures like this are increasingly attracting tactical capital looking to amplify returns during regional rebounds.
Also
- Leverage Shares 2X Long GLW Daily ETF (GLWG.US): Established in March 2026, this fund provides 2x leverage on Corning's daily performance. Its 0.75% total expense ratio is about 40% lower than average single-stock leveraged ETFs, drawing short-term bullish flows.
- Leverage Shares 2X Long KLAC Daily ETF (KLAG.US): Another single-stock leveraged play, KLAG is designed specifically for active traders aiming to magnify the single-day moves of KLA Corp.
- Direxion Shares ETF Trust Daily FTSE China Bear 3X (YANG.US): As an aggressive ETF seeking 300% inverse results of the FTSE China 50 Index, YANG continues to see high turnover during volatile trading sessions.
- Cambria ETF Trust Cannabis ETF (TOKE.US): Against the backdrop of global legalization efforts, this actively managed ETF keeps hunting for companies across all market caps that derive the majority of their revenue from legal cannabis use.
This article does not constitute investment advice.
